Balanced news tone
News Sentiment
DHR sentiment intelligence
Danaher Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
57
Balanced news tone
38 relevant articles
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-4.2% over one week, +10.7% over four weeks, trend inactive, and below fair value.
Danaher (DHR) Expands Ebola Testing And AI Drug Filing Push Through Two Subsidiaries
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
79/100 classification
One-week reaction
-4.2%
Price reacting lower
Trend fit
Trend inactive
10.7% over four weeks
Fair value
-24.1%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
13
Neutral
24
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Medical Device Network
Direct company coverage
Danaher acquires Masimo for $9.9bn to bolster diagnostics business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Feb 2026 08:00
- Source
- Medical Device Network
Investing.com
Direct company coverage
Danaher closes in on nearly $10 billion deal for Masimo, FT reports By Reuters
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Feb 2026 08:00
- Source
- Investing.com
Investing.com
Direct company coverage
Med tech firm Masimo spikes on report Danaher is nearing $10 bn purchase
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- Investing.com
Investing.com
Direct company coverage
Danaher stock rating reiterated at Buy by TD Cowen despite guidance pressure
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 29 Jan 2026 08:00
- Source
- Investing.com
Investing.com
Direct company coverage
Danaher stock price target raised to $254 from $250 at Evercore ISI
- Tone
- Positive 64/100
- Event
- Analyst action
- Published
- 28 Jan 2026 08:00
- Source
- Investing.com
Investing.com
Direct company coverage
Goldman Sachs initiates Danaher stock with Buy rating on bioprocessing strength
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 09 Dec 2025 08:00
- Source
- Investing.com
The Acquirer's Multiple
Direct company coverage
Why Top Investors Are Buying Danaher (DHR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jul 2025 07:00
- Source
- The Acquirer's Multiple
Market source
Direct company coverage
Why Danaher Corporation (DHR) is the Best Medical Device Stock to Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Feb 2025 08:00
- Source
- Market source